Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield)
Bağlantıyı al
Facebook
X
Pinterest
E-posta
Diğer Uygulamalar
via News (English) - World Health Organization https://ift.tt/3xePbiD
Yorumlar
Yorum Gönder